Stock Events

Kalbe Farma Tbk PT 

€0.09
31
+€0+0% Thursday 13:29

Statistics

Day High
0.09
Day Low
0.08
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
4.63B
P/E Ratio
0
Dividend Yield
1.93%
Dividend
0

Upcoming

Dividends

1.93%Dividend Yield
10Y Growth
3.02%
5Y Growth
0.91%
3Y Growth
-0.87%
1Y Growth
-25.4%

Earnings

30OctExpected
Q3 2021
Q1 2022
Q2 2022
Q3 2022
Q1 2024
Q2 2024
Next
0
6.26
12.53
18.79
Expected EPS
0.00107392
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LCLA.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia.
Show more...
CEO
Mr. . Vidjongtius
Employees
12992
Country
ID
ISIN
ID1000125107
WKN
000A1J5U9

Listings